Prosecution Insights
Last updated: May 29, 2026

UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ

4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Portfolio Summary

4
Total Pending OAs
2
Non-Final OAs
1
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due ≤ 30 days (2)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (50%)
2
Easy (50%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (50%)
§112 only2 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
50% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
RAMSEY, JEREMY C 1 52.3% +46.8%
BERHANU, ETSUB D 1 65.5% +24.5%
SINGH, ANOOP KUMAR 1 42.8% +67.6%
MCCOLLUM, ANDREA K 1 60.7% +32.1%

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
16970688 Novel IL-4-/IL-13-derived peptide compounds for the treatment or prevention of neurodegenerative or neuroinflammatory diseases MCCOLLUM, ANDREA K 99d overdue
18029149 Method for classifying a polysomnography recording into defined sleep stages BERHANU, ETSUB D 16d
18730744 ROLLER SHUTTER ROD AND ROLLER SHUTTER RAMSEY, JEREMY C 22d
18041244 Autologous, prevascularized breast tissue constructs produced in a 3D printing method, and methods for producing same SINGH, ANOOP KUMAR 84d

Top Art Units

Art UnitApps
3634 1
3791 1
1632 1
1674 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18730744 ROLLER SHUTTER ROD AND ROLLER SHUTTER RAMSEY, JEREMY C 3634 §103 Non-Final OA 22d Pending Jul 19, 2024
18029149 Method for classifying a polysomnography recording into defined sleep stages BERHANU, ETSUB D 3791 §103 Final Rejection 16d Pending Mar 29, 2023
18041244 Autologous, prevascularized breast tissue constructs produced in a 3D printing method, and methods for producing same SINGH, ANOOP KUMAR 1632 §112 Non-Final OA 84d Pending Feb 10, 2023
16970688 Novel IL-4-/IL-13-derived peptide compounds for the treatment or prevention of neurodegenerative or neuroinflammatory diseases MCCOLLUM, ANDREA K 1674 §112 Non-Final OA 99d overdue Pending Aug 18, 2020

Managing UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month